Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 494,900 | 354,200 | 236,100 | 123,400 | 811,100 |
| Depreciation Amortization | 65,800 | 51,300 | 32,800 | 16,000 | 68,600 |
| Income taxes - deferred | -95,000 | -1,100 | 2,200 | 4,100 | -71,100 |
| Accounts receivable | -38,300 | -28,300 | -39,500 | -36,500 | -26,800 |
| Other Working Capital | 64,200 | 24,200 | -31,700 | -72,700 | 200,900 |
| Other Operating Activity | 58,100 | 45,600 | 43,500 | 39,000 | 39,600 |
| Operating Cash Flow | $549,700 | $445,900 | $243,400 | $73,300 | $1,022,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,200 | 225,300 | 4,400 | -93,100 | -359,600 |
| PPE Investments | -102,700 | -65,200 | -39,200 | -20,800 | -79,800 |
| Net Acquisitions | -331,600 | -320,100 | N/A | N/A | -15,000 |
| Purchase Of Investment | -1,313,900 | -308,000 | -206,600 | -85,000 | -171,600 |
| Sale Of Investment | 1,442,700 | 126,300 | 78,700 | 18,300 | 3,800 |
| Purchase Sale Intangibles | -3,800 | N/A | N/A | N/A | -10,800 |
| Other Investing Activity | -1,400 | -1,700 | -5,100 | 300 | -10,800 |
| Investing Cash Flow | $-316,100 | $-343,400 | $-167,800 | $-180,300 | $-633,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 20,700 | N/A | N/A | N/A |
| Debt Issued | 31,400 | N/A | 13,300 | 7,400 | 226,300 |
| Debt Repayment | -29,500 | -18,800 | -14,700 | -8,200 | -239,000 |
| Common Stock Issued | 87,200 | 60,000 | 42,500 | 23,500 | 113,300 |
| Common Stock Repurchased | -280,100 | -180,100 | -179,900 | -101,000 | -300,900 |
| Other Financing Activity | 32,400 | 19,300 | 16,300 | 6,400 | 47,300 |
| Financing Cash Flow | $-158,600 | $-98,900 | $-122,500 | $-71,900 | $-153,000 |
| Exchange Rate Effect | -10,400 | -11,300 | -9,300 | -17,900 | -2,900 |
| Beginning Cash Position | 653,800 | 653,800 | 653,800 | 653,800 | 420,400 |
| End Cash Position | 718,400 | 646,100 | 597,600 | 457,000 | 653,800 |
| Net Cash Flow | $64,600 | $-7,700 | $-56,200 | $-196,800 | $233,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 549,700 | 445,900 | 243,400 | 73,300 | 1,022,300 |
| Capital Expenditure | -102,700 | -65,200 | -39,200 | -20,800 | -82,900 |
| Free Cash Flow | 447,000 | 380,700 | 204,200 | 52,500 | 939,400 |